This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A phase II study to assess the efficacy and safety...
Clinical trial

A phase II study to assess the efficacy and safety of frontline combination of dasatinib (SPRYCEL�) and pegylated-interferon alpha 2b (Peg-IFN?2b) therapy in patients newly diagnosed with chronic phase chronic myeloid leukaemia (CP-CML)

Read time: 1 mins
Last updated:21st May 2013
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest